Acitretin monotherapy in acrodermatitis continua Hallopeau

Acta Derm Venereol. 1989;69(4):344-6.

Abstract

In a patient affected with acrodermatitis continua Hallopeau, acitretin (Ro 10-1670) monotherapy resulted in a complete clearance of pustulation at a dosage of 45 mg per day. At this dosage the leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes was markedly inhibited.

Publication types

  • Case Reports

MeSH terms

  • Acitretin
  • Acrodermatitis / drug therapy*
  • Acrodermatitis / pathology
  • Aged
  • Cell Movement
  • Fingers*
  • Humans
  • Male
  • Neutrophils / pathology
  • Tretinoin / administration & dosage
  • Tretinoin / analogs & derivatives*
  • Tretinoin / therapeutic use

Substances

  • Tretinoin
  • Acitretin